|
GB8909891D0
(en)
*
|
1989-04-28 |
1989-06-14 |
Riker Laboratories Inc |
Device
|
|
UA26230A
(uk)
*
|
1990-03-02 |
1999-07-19 |
Глексо Груп Лімітед |
Іhгалятор для спільhого використаhhя з лікувальhим блоком і лікувальhий блок
|
|
US6536427B2
(en)
*
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
HU213221B
(en)
*
|
1990-03-02 |
1997-03-28 |
Glaxo Group Ltd |
Inhalation device and medicine packet for device
|
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
|
WO1994006497A1
(en)
*
|
1992-09-11 |
1994-03-31 |
Glaxo Group Limited |
Inhalation device
|
|
SE9203570D0
(sv)
*
|
1992-11-27 |
1992-11-27 |
Astra Ab |
Inhaler for multiple use
|
|
EP0806214B1
(en)
*
|
1992-12-24 |
2001-11-28 |
Aventis Pharma Limited |
Inhaler devices
|
|
US5896855A
(en)
*
|
1992-12-24 |
1999-04-27 |
Rhone-Poulenc Rorer Limited |
Multi dose inhaler apparatus
|
|
GB9326574D0
(en)
*
|
1993-12-31 |
1994-03-02 |
King S College London |
Dry power inhalers
|
|
JPH07219571A
(ja)
*
|
1994-01-31 |
1995-08-18 |
Yukihiko Takino |
カラオケ曲目表示装置
|
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
|
GB9417399D0
(en)
|
1994-08-30 |
1994-10-19 |
Scherer Corp R P |
Ocular treatment device
|
|
ES2208980T3
(es)
*
|
1994-08-30 |
2004-06-16 |
Pharmacia Ab |
Embalaje para dosis fluidas, dispositivo de tratamiento ocular y uso del mismo.
|
|
DE29501527U1
(de)
*
|
1995-02-01 |
1995-03-30 |
Hugo Kern und Liebers GmbH & Co. Platinen- und Federnfabrik, 78713 Schramberg |
Vorrichtung zur Erzeugung inhalierbarer Wirkstoffpartikel
|
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
SE9503344D0
(sv)
*
|
1995-09-27 |
1995-09-27 |
Astra Ab |
Inhalation device
|
|
DE69618624T2
(de)
|
1996-01-03 |
2002-08-08 |
Glaxo Group Ltd., Greenford |
Inhaliervorrichtung
|
|
USD395499S
(en)
|
1996-04-08 |
1998-06-23 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
|
GB9626233D0
(en)
*
|
1996-12-18 |
1997-02-05 |
Chawla Brinda P S |
Medicament packaging and deliveery device
|
|
SE9700424D0
(sv)
*
|
1997-02-07 |
1997-02-07 |
Astra Ab |
Powder inhaler
|
|
US6006747A
(en)
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
SE9702796D0
(sv)
*
|
1997-07-25 |
1997-07-25 |
Pharmacia & Upjohn Ab |
A device at a pharmaceutical container or inhaler
|
|
CA2212430A1
(en)
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
NZ504021A
(en)
*
|
1997-10-17 |
2003-04-29 |
Systemic Pulmonary Delivery Lt |
Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
|
|
GB9722285D0
(en)
*
|
1997-10-23 |
1997-12-17 |
Rhone Poulenc Rorer Ltd |
Inhalation device
|
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
USD412978S
(en)
|
1997-12-02 |
1999-08-17 |
Dura Pharmaceuticals, Inc. |
Inhaler
|
|
AU2281300A
(en)
*
|
1999-01-22 |
2000-08-07 |
Glaxo Group Limited |
Inhalation device
|
|
GB9905538D0
(en)
|
1999-03-10 |
1999-05-05 |
Glaxo Group Ltd |
A device
|
|
US6601729B1
(en)
|
1999-03-26 |
2003-08-05 |
Papp Enterprises, Llc |
Automated portable medication radial dispensing apparatus and method using a carrier tape
|
|
GB9909354D0
(en)
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
|
GB9909357D0
(en)
*
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
US6730066B1
(en)
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
|
GB9925934D0
(en)
|
1999-11-03 |
1999-12-29 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
US20010029947A1
(en)
*
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
|
US7171965B2
(en)
*
|
2000-02-01 |
2007-02-06 |
Valois S.A.S. |
Breath actuated dry powder inhaler and tape dose strip
|
|
GB0004456D0
(en)
*
|
2000-02-26 |
2000-04-19 |
Glaxo Group Ltd |
Medicament dispenser
|
|
DE10011120A1
(de)
|
2000-03-09 |
2001-09-13 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
|
AU2001250901A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Dura Pharmaceuticals, Inc. |
Containers for individual doses of an inhalable pharmaceutical
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
|
TWI290473B
(en)
*
|
2000-05-10 |
2007-12-01 |
Alliance Pharma |
Phospholipid-based powders for drug delivery
|
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
|
GB0012465D0
(en)
*
|
2000-05-24 |
2000-07-12 |
Glaxo Group Ltd |
Monitoring method
|
|
GB0013619D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Glaxo Group Ltd |
Sample container
|
|
GB0014851D0
(en)
*
|
2000-06-16 |
2000-08-09 |
Glaxo Group Ltd |
Novel pharmaceutical formulation
|
|
GB0015034D0
(en)
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
|
PE20020075A1
(es)
*
|
2000-06-23 |
2002-02-05 |
Norton Healthcare Ltd |
Dispositivo contador de dosis para inhalador de medicamento
|
|
US7080644B2
(en)
*
|
2000-06-28 |
2006-07-25 |
Microdose Technologies, Inc. |
Packaging and delivery of pharmaceuticals and drugs
|
|
EP1301230A1
(en)
|
2000-07-15 |
2003-04-16 |
Glaxo Group Limited |
Medicament dispenser
|
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
|
EP1305329B2
(en)
|
2000-08-05 |
2015-03-18 |
Glaxo Group Limited |
6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
|
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
WO2002013897A2
(en)
|
2000-08-14 |
2002-02-21 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
|
AUPR020400A0
(en)
*
|
2000-09-19 |
2000-10-12 |
Glaxo Wellcome Australia Ltd |
Inhalation device
|
|
GB0026647D0
(en)
*
|
2000-10-31 |
2000-12-13 |
Glaxo Group Ltd |
Medicament dispenser
|
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
DE10111945B4
(de)
*
|
2001-03-13 |
2006-03-09 |
Alexander Christ |
Kapselspender
|
|
WO2002076933A1
(en)
|
2001-03-22 |
2002-10-03 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
|
US6766799B2
(en)
*
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
|
EP2039700A2
(en)
|
2001-04-30 |
2009-03-25 |
Glaxo Group Limited |
Novel anti-inflammatory androstane derivatives
|
|
US7766013B2
(en)
*
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
|
FI20011317A0
(fi)
*
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Jauheinhalaattori
|
|
WO2003013633A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Glaxo Group Limited |
Inhalation device with a pharmaceutical composition
|
|
DE60230425D1
(de)
|
2001-09-14 |
2009-01-29 |
Glaxo Group Ltd |
Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
|
|
US8337816B2
(en)
|
2001-09-17 |
2012-12-25 |
Glaxo Group Limited |
Dry powder medicament formulations
|
|
US6871647B2
(en)
|
2001-09-19 |
2005-03-29 |
Advent Pharmaceuticals Pty Ltd |
Inhaler
|
|
GB0125135D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0125132D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0125134D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0127989D0
(en)
*
|
2001-11-22 |
2002-01-16 |
Glaxo Group Ltd |
Medicament dispensing system
|
|
GB0130055D0
(en)
*
|
2001-12-14 |
2002-02-06 |
Technology Innovation Ltd |
Medicament packaging
|
|
ATE508735T1
(de)
*
|
2001-12-19 |
2011-05-15 |
Novartis Ag |
Pulmonale verabreichung von aminoglykosiden
|
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
|
JP2005527260A
(ja)
*
|
2002-01-25 |
2005-09-15 |
グラクソ グループ リミテッド |
薬剤ディスペンサ
|
|
GB0217199D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
|
US20060187750A1
(en)
*
|
2002-03-01 |
2006-08-24 |
Victor Aldrich |
Rotary blending apparatus and system
|
|
AU2003209475A1
(en)
*
|
2002-03-07 |
2003-09-16 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
|
GB0205572D0
(en)
*
|
2002-03-09 |
2002-04-24 |
Chawla Brinda P S |
Medicament delivery and packaging
|
|
EP1487716A4
(en)
*
|
2002-03-26 |
2008-05-21 |
Glaxo Group Ltd |
METHOD FOR PRODUCING A LAMINATE ARRANGEMENT AND PRODUCTS THEREOF PRODUCED
|
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
|
EP1497261B1
(en)
|
2002-04-25 |
2007-12-19 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
|
JP2005524134A
(ja)
*
|
2002-04-25 |
2005-08-11 |
グラクソ グループ リミテッド |
環境条件を検知するための磁気音響センサーシステムおよびそれに関連する方法
|
|
GB0209526D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0209528D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
|
JP2005526261A
(ja)
*
|
2002-05-15 |
2005-09-02 |
グラクソ グループ リミテッド |
医薬包装内の温度および水分プロファイルを測定するための微小電気機械システムおよび方法
|
|
GB0216831D0
(en)
*
|
2002-07-19 |
2002-08-28 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
JP2005533581A
(ja)
*
|
2002-07-25 |
2005-11-10 |
グラクソ グループ リミテッド |
薬剤ディスペンサ
|
|
US20050251289A1
(en)
*
|
2002-07-25 |
2005-11-10 |
Bonney Stanley G |
Medicament dispenser
|
|
US20070139442A1
(en)
*
|
2002-09-13 |
2007-06-21 |
Robinson Karl E |
Coated blending system
|
|
GB0221493D0
(en)
*
|
2002-09-17 |
2002-10-23 |
Glaxo Group Ltd |
Method for loading a medicament dispenser with a medicament carrier
|
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
|
EP1554264B1
(en)
*
|
2002-10-22 |
2007-08-08 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
|
ATE390407T1
(de)
|
2002-10-28 |
2008-04-15 |
Glaxo Group Ltd |
Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
|
|
AU2003293361A1
(en)
*
|
2002-12-18 |
2004-07-29 |
Glaxo Group Limited |
Drug delivery system with vented mouthpiece
|
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0303870D0
(en)
*
|
2003-02-20 |
2003-03-26 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
|
WO2004082557A2
(en)
*
|
2003-03-15 |
2004-09-30 |
Brin Tech International Limited |
Package for and formulation of medicaments
|
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
SE527069C2
(sv)
*
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
|
AR045914A1
(es)
|
2003-07-17 |
2005-11-16 |
Glaxo Group Ltd |
Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima
|
|
GB0317374D0
(en)
*
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
|
PL1677795T3
(pl)
|
2003-10-14 |
2011-05-31 |
Glaxo Group Ltd |
Antagoniści receptora muskarynowego acetylocholiny
|
|
GB2407042B
(en)
*
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
|
JP2007509061A
(ja)
|
2003-10-17 |
2007-04-12 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
|
WO2005044187A2
(en)
*
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
|
EP1691782A1
(en)
*
|
2003-12-03 |
2006-08-23 |
Microdrug AG |
Medical product containing tiotropium
|
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
|
US7631812B2
(en)
*
|
2003-12-10 |
2009-12-15 |
Williams Troy P |
Foldable transaction card systems
|
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO2005076872A2
(en)
*
|
2004-02-06 |
2005-08-25 |
Microdose Technologies, Inc. |
A blister pack for use with an inhalation device
|
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
|
PL1730676T3
(pl)
*
|
2004-02-16 |
2014-04-30 |
Glaxo Group Ltd |
Licznik do stosowania z dozownikiem leku
|
|
WO2005087236A1
(en)
*
|
2004-03-11 |
2005-09-22 |
Glaxo Group Limited |
Novel m3 muscarinic acetylcholine receptor antagonists
|
|
WO2005095407A1
(en)
|
2004-03-17 |
2005-10-13 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
|
BRPI0509382A
(pt)
|
2004-04-02 |
2007-09-18 |
Glaxo Group Ltd |
processo para a preparação de um sal monocloridrato de composto, monocloridrato cristalino, processo para obter monocloridrato cristalino, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, uso de monocloridrato cristalino, formulação farmacêutica, e, combinação
|
|
KR20070001285A
(ko)
*
|
2004-04-24 |
2007-01-03 |
인레인지 시스템즈, 인크. |
통합된 비순차적 원격 약물 관리 및 순응 시스템
|
|
US7828147B2
(en)
*
|
2004-04-24 |
2010-11-09 |
Inrange Systems, Inc. |
Multi-layer medication carrier
|
|
MY144753A
(en)
|
2004-04-27 |
2011-10-31 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
|
JP2007537261A
(ja)
|
2004-05-13 |
2007-12-20 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
ES2317245T3
(es)
|
2004-05-31 |
2009-04-16 |
Laboratorios Almirall, S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
|
SE0401654D0
(sv)
*
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
A support structure for a medicament
|
|
FR2872798B1
(fr)
*
|
2004-07-09 |
2007-10-05 |
Valois Sas |
Ensemble de blisters pour dispositif d'inhalation
|
|
GB0418278D0
(en)
*
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
|
EA200700743A1
(ru)
*
|
2004-10-06 |
2007-10-26 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Устройство для распыления порошка, устройство для хранения порошка и способ распыления порошка
|
|
WO2006053059A2
(en)
*
|
2004-11-12 |
2006-05-18 |
Glaxo Group Limited |
Sensor system with acoustic transducer
|
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
|
WO2006074897A1
(en)
*
|
2005-01-11 |
2006-07-20 |
Glaxo Group Limited |
Cinnamate salts of a beta-2 adrenergic agonist
|
|
FR2881111B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
FR2881118B1
(fr)
*
|
2005-01-25 |
2007-04-20 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
FR2881117B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
FR2881119B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
MX2007009656A
(es)
|
2005-02-10 |
2007-11-07 |
Glaxo Group Ltd |
Proceso para elaborar lactosa utilizando tecnicas de clasificacion previa y formulaciones farmaceuticas formadas de la misma.
|
|
US20090029901A1
(en)
*
|
2005-02-10 |
2009-01-29 |
Marian Wood-Kaczmar |
Process for Crystallizing Lactose Particles for Use in Pharmaceutical Formulations
|
|
UY29440A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
TW200724142A
(en)
|
2005-03-25 |
2007-07-01 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1879579A1
(en)
*
|
2005-05-04 |
2008-01-23 |
Boehringer Ingelheim International GmbH |
Inhalation device containing plural doses of a pharmaceutical composition
|
|
USD550350S1
(en)
*
|
2005-05-11 |
2007-09-04 |
Vectura Limited |
Pharmaceutical product
|
|
GB0509952D0
(en)
|
2005-05-16 |
2005-06-22 |
Glaxo Group Ltd |
Fault indicator
|
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
|
EP1937267A4
(en)
*
|
2005-08-02 |
2009-08-26 |
Glaxo Group Ltd |
M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS
|
|
WO2007016650A2
(en)
*
|
2005-08-02 |
2007-02-08 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
|
WO2007022351A2
(en)
|
2005-08-18 |
2007-02-22 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists
|
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
|
US20070068837A1
(en)
*
|
2005-09-29 |
2007-03-29 |
D Angelis Bruno S |
Wound dressing dispenser
|
|
GB0521563D0
(en)
|
2005-10-21 |
2005-11-30 |
Glaxo Group Ltd |
Novel compounds
|
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
|
AU2007210177C1
(en)
|
2006-01-31 |
2012-11-01 |
Oriel Therapeutics, Inc. |
Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
|
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
|
JP5188991B2
(ja)
*
|
2006-03-03 |
2013-04-24 |
エスティーシー.ユーエヌエム |
空力弾性分配メカニズムを有するドライパウダー吸入器
|
|
GB0605150D0
(en)
*
|
2006-03-14 |
2006-04-26 |
Glaxo Group Ltd |
Counter For Use With A Medicament Dispenser
|
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
|
EP1844809A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator
|
|
US7943651B2
(en)
|
2006-04-20 |
2011-05-17 |
Glaxo Group Limited |
Compounds
|
|
GR1005668B
(el)
*
|
2006-05-09 |
2007-10-02 |
|
Συσκευη εισπνοων ξηρης σκονης για την ταυτοχρονη χορηγηση περισσοτερων απο μιας φαρμακευτικων ουσιων
|
|
GR1005620B
(el)
*
|
2006-05-09 |
2007-09-03 |
|
Βελτιωση συσκευης εισπνοων ξηρης σκονης
|
|
US9457161B2
(en)
|
2006-05-18 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
|
DE102006023662A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
|
FR2904229B1
(fr)
*
|
2006-07-25 |
2008-10-10 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
SI2046787T1
(sl)
|
2006-08-01 |
2011-07-29 |
Glaxo Group Ltd |
Pirazolo(3,4-b)piridinske spojine in njihova uporaba kot PDE4 inhibitorji
|
|
CA2667225C
(en)
|
2006-10-25 |
2015-06-09 |
Novartis Ag |
Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
|
|
GB0622827D0
(en)
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
|
FR2909643B1
(fr)
*
|
2006-12-11 |
2011-03-04 |
Valois Sas |
Dispositif de distribution de produit fluide
|
|
US8225784B2
(en)
*
|
2006-12-11 |
2012-07-24 |
Valois Sas |
Fluid product dispensing device
|
|
US20080163610A1
(en)
*
|
2007-01-05 |
2008-07-10 |
Matthew Thomas Baird |
Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
|
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
|
JP5198801B2
(ja)
*
|
2007-05-30 |
2013-05-15 |
株式会社吉野工業所 |
吸引式投薬器
|
|
WO2008156586A2
(en)
*
|
2007-06-12 |
2008-12-24 |
Alkermes, Inc. |
Inhalation device for powdered substances
|
|
EP2162174A1
(en)
*
|
2007-07-06 |
2010-03-17 |
Boehringer Ingelheim International GmbH |
Inhaler
|
|
EP2011538B1
(en)
|
2007-07-06 |
2016-02-17 |
Vectura Delivery Devices Limited |
Inhaler
|
|
EP2011536A1
(en)
*
|
2007-07-06 |
2009-01-07 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhaler
|
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
|
WO2009082341A1
(en)
|
2007-12-20 |
2009-07-02 |
Astrazeneca Ab |
Device and method for deaggregating powder 854
|
|
WO2009093969A1
(en)
|
2008-01-23 |
2009-07-30 |
Astrazeneca Ab |
A medicament-containing dispenser provided with a display for presenting indicia to a user
|
|
EP2082759A1
(en)
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
|
EP2082758A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
|
EP2082764A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
|
EP2096105A1
(en)
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2108641A1
(en)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
|
EP2113503A1
(en)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
|
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
|
US8517009B2
(en)
|
2008-07-13 |
2013-08-27 |
Map Pharmaceuticals, Inc. |
Methods and apparatus for delivering aerosolized medication
|
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
|
KR101311977B1
(ko)
|
2008-09-26 |
2013-09-26 |
오리엘 테라퓨틱스, 인크. |
분리된 공기통로 채널들을 갖는 공기통로 디스크들 및 관련된 디스크들을 구비한 흡입기 및 이와 관련된 방법
|
|
CA2732840C
(en)
|
2008-09-26 |
2016-07-05 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with dual piercing members and related devices and methods
|
|
WO2010036355A2
(en)
*
|
2008-09-26 |
2010-04-01 |
Oriel Therapeutics, Inc. |
Inhaler mechanisms with radially biased piercers and related methods
|
|
WO2010039201A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
|
ES2561899T3
(es)
*
|
2008-10-01 |
2016-03-01 |
Oriel Therapeutics, Inc. |
Inhaladores de polvo seco con mecanismos de perforación giratorios y dispositivos y métodos relacionados
|
|
KR20110083651A
(ko)
*
|
2008-10-08 |
2011-07-20 |
아스트라제네카 아베 |
가청 표시기 수단을 갖는 흡입기
|
|
GB201020130D0
(en)
|
2010-11-26 |
2011-01-12 |
Vectura Delivery Devices Ltd |
Inhaler
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
EP2198908A1
(en)
*
|
2008-12-19 |
2010-06-23 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
|
CN102348707A
(zh)
|
2009-01-13 |
2012-02-08 |
葛兰素集团有限公司 |
作为syk激酶抑制剂的嘧啶甲酰胺衍生物
|
|
NZ574666A
(en)
*
|
2009-02-05 |
2009-04-30 |
Nexus6 Ltd |
A medicament inhaler holder that uses optical means to count and display the number of doses used
|
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
|
EP2221055A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
|
|
EP2221297A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
|
|
HUE067290T2
(hu)
|
2009-02-26 |
2024-10-28 |
Glaxo Group Ltd |
4-{(1 R)-2-[(6-{2-[(2,6-diklórbenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroxi-metil)fenolt tartalmazó gyógyszerkészítmények
|
|
EP2226323A1
(en)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
|
|
EP2228368A1
(en)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
|
AR076373A1
(es)
|
2009-04-24 |
2011-06-08 |
Glaxo Group Ltd |
N-pirazolil carboxamidas como inhibidores de canales de calcio
|
|
WO2010122088A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
DE202009006141U1
(de)
|
2009-04-25 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Inhalator
|
|
CN102438578A
(zh)
|
2009-05-07 |
2012-05-02 |
基伊埃制药系统有限公司 |
药片生产模块和用于连续生产药片的方法
|
|
EA021831B1
(ru)
|
2009-05-18 |
2015-09-30 |
Нортон Хэлткэа Лимитед |
Сухопорошковый ингалятор
|
|
CN102458542B
(zh)
|
2009-05-18 |
2014-11-05 |
诺顿·希尔思凯尔有限公司 |
干燥粉末吸入器
|
|
US9125999B2
(en)
|
2009-05-18 |
2015-09-08 |
Adamis Pharmaceuticals Corporation |
Dry powder inhaler dose counters
|
|
BRPI1009072B1
(pt)
|
2009-05-18 |
2021-06-22 |
Adamis Pharmaceuticals Corporation |
Dispositivo para inalação de pó seco e dispositivo para armazenamento de pó seco
|
|
ES2498166T3
(es)
|
2009-05-18 |
2014-09-24 |
Norton Healthcare Limited |
Inhalador de polvo seco
|
|
US8763606B2
(en)
*
|
2009-05-21 |
2014-07-01 |
Microdose Therapeutx, Inc. |
Rotary cassette system for dry powder inhaler
|
|
US8985101B2
(en)
|
2009-05-21 |
2015-03-24 |
Microdose Therapeutx, Inc. |
Method and device for clamping a blister within a dry powder inhaler
|
|
JP2012530140A
(ja)
|
2009-06-16 |
2012-11-29 |
メルク・シャープ・アンド・ドーム・コーポレーション |
グルココルチコイド受容体アゴニストとしての新規[3,2−c]ヘテロアリールステロイド、組成物およびこの使用
|
|
EP2448623B1
(en)
|
2009-07-01 |
2017-12-20 |
AstraZeneca AB |
Dispenser and method for entraining powder in an airflow
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
BR112012010706A2
(pt)
|
2009-11-05 |
2016-03-29 |
Glaxosmithkline Llc |
composto, composição farmacêutica, combinação do produto farmacêutico, uso de um composto, e, métodos para o tratamento de uma doença ou condição, e para inibir um bromodomínio
|
|
EP2955524A3
(en)
|
2009-11-05 |
2016-03-23 |
GlaxoSmithKline LLC |
Novel process
|
|
WO2011054845A1
(en)
|
2009-11-05 |
2011-05-12 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2322176A1
(en)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
|
|
CA2779488A1
(en)
|
2009-11-12 |
2011-05-19 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
TR200909791A2
(tr)
|
2009-12-25 |
2011-07-21 |
B�Lg�� Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
|
CA2784041C
(en)
*
|
2010-01-05 |
2017-11-07 |
Microdose Therapeutx, Inc. |
Inhalation device and method
|
|
US8490795B2
(en)
|
2010-02-01 |
2013-07-23 |
Mallinckrodt Llc |
Container and method for facilitating disposal of unused pharmaceutical product
|
|
US9046403B2
(en)
*
|
2010-02-01 |
2015-06-02 |
Mallinckrodt Llc |
Systems and methods for managing use of a medicament
|
|
JP2013523375A
(ja)
*
|
2010-04-13 |
2013-06-17 |
ビルギチ,マフムト |
乾燥粉末吸入器のマウスピースボタン
|
|
EP2380890A1
(en)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2386555A1
(en)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
|
|
EP2394998A1
(en)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
|
|
FR2961186B1
(fr)
*
|
2010-06-11 |
2012-07-13 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
EP2585465B1
(en)
|
2010-06-22 |
2014-11-12 |
GlaxoSmithKline LLC |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
|
FR2962345B1
(fr)
|
2010-07-09 |
2013-06-21 |
Valois Sas |
Inhalateur unidose de poudre seche pour blister pelable.
|
|
CA2804959A1
(en)
|
2010-07-21 |
2012-01-26 |
Astrazeneca Ab |
Inhaler
|
|
WO2012025474A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Indazole compounds
|
|
WO2012025473A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Cc.chemokine receptor 4 antagonists
|
|
EP3461474B1
(en)
|
2010-08-31 |
2020-11-11 |
GlaxoSmithKline Intellectual Property Development Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
|
WO2012028663A1
(en)
|
2010-08-31 |
2012-03-08 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
|
EP2441755A1
(en)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
|
|
EP2630127A1
(en)
|
2010-10-21 |
2013-08-28 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
|
EP2630126B1
(en)
|
2010-10-21 |
2015-01-07 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, immune and inflammatory conditions
|
|
WO2012064286A1
(en)
|
2010-11-11 |
2012-05-18 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
|
EP2457900A1
(en)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
New pyrazole derivatives having CRTh2 antagonistic behaviour
|
|
EP2463289A1
(en)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
|
ES2646748T3
(es)
|
2010-12-07 |
2017-12-15 |
Respira Therapeutics, Inc. |
Inhalador de polvo seco
|
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
|
US8834411B2
(en)
|
2011-04-06 |
2014-09-16 |
Mystic Pharmaceuticals, Inc. |
Medical devices for dispensing powders
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2527344A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
|
|
EP2526945A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
New CRTH2 Antagonists
|
|
BR112013031570A2
(pt)
|
2011-06-08 |
2017-03-21 |
Glaxo Group Ltd |
inalador de pó seco.
|
|
PH12013502497A1
(en)
|
2011-06-08 |
2019-07-17 |
Glaxo Group Ltd |
Combination comprising umeclidinium and a corticosteroid
|
|
EP2548876A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists
|
|
EP2548863A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists.
|
|
EP2554544A1
(en)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1h)-one derivatives as jak inhibitors
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2578570A1
(en)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
|
|
EP2592078A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
|
EP2592077A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
|
US20150010527A1
(en)
|
2012-02-01 |
2015-01-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
|
GB2499597A
(en)
*
|
2012-02-21 |
2013-08-28 |
Innovata Biomed Ltd |
Dry powder inhaler with stepped rotation of metering member
|
|
EP3421042B1
(en)
|
2012-03-07 |
2024-04-17 |
Beyond Air Ltd |
Inhalation of nitric oxide for treating respiratory diseases
|
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
|
EP2647627A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
|
|
DE102012104850A1
(de)
|
2012-04-05 |
2013-10-10 |
Alfred Von Schuckmann |
Vorrichtung zur portionierten Ausgabe von Medikamenten
|
|
US9763965B2
(en)
|
2012-04-13 |
2017-09-19 |
Glaxosmithkline Intellectual Property Development Limited |
Aggregate particles
|
|
US9428452B2
(en)
|
2012-04-27 |
2016-08-30 |
Glaxo Group Limited |
Compounds
|
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2662105B1
(de)
|
2012-05-09 |
2017-01-18 |
Boehringer Ingelheim International GmbH |
Zerstäuber
|
|
FR2990872B1
(fr)
*
|
2012-05-24 |
2015-05-15 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
WO2013176639A1
(en)
*
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Inhaler device with an improved blister advancement mechanism
|
|
GB2502350A
(en)
|
2012-05-25 |
2013-11-27 |
Vectura Delivery Devices Ltd |
Inhaler having means to control the force applied to an actuating lever
|
|
EA201492044A1
(ru)
*
|
2012-05-25 |
2015-05-29 |
Арвен Айлак Санайи Ве Тиджарет А.С. |
Ингалятор, содержащий внутренний корпус, имеющий канал для воздуха
|
|
EP2666465A1
(en)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Novel dosage and formulation
|
|
EP2668941A1
(en)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Novel dosage form and formulation of abediterol
|
|
CA2876446A1
(en)
|
2012-07-05 |
2014-01-09 |
Glaxo Group Limited |
Inhaler device
|
|
WO2014060431A1
(en)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
|
SG11201503697TA
(en)
|
2012-11-28 |
2015-06-29 |
Intercept Pharmaceuticals Inc |
Treatment of pulmonary disease
|
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
|
JP5350530B1
(ja)
*
|
2012-12-07 |
2013-11-27 |
ニップファーマ株式会社 |
薬剤吸入デバイス
|
|
EP2934594B1
(en)
|
2012-12-18 |
2019-09-04 |
Almirall, S.A. |
Cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities .
|
|
AR094797A1
(es)
|
2013-02-15 |
2015-08-26 |
Almirall Sa |
Derivados de pirrolotriazina como inhibidores de pi3k
|
|
CN105189515B
(zh)
|
2013-03-14 |
2018-07-03 |
葛兰素史克知识产权第二有限公司 |
作为溴结构域抑制剂的呋喃并吡啶类
|
|
CA2901537C
(en)
|
2013-03-14 |
2021-09-07 |
Glaxosmithkline Intellectual Property (No.2) Limited |
2,3-disubstituted 1- acyl-4-amino-1 ,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
|
|
GB201305668D0
(en)
|
2013-03-28 |
2013-05-15 |
Glaxosmithkline Ip Dev Ltd |
Avs6 Integrin Antagonists
|
|
JP6105373B2
(ja)
*
|
2013-04-25 |
2017-03-29 |
株式会社吉野工業所 |
吸引器具
|
|
JP5985434B2
(ja)
*
|
2013-04-25 |
2016-09-06 |
株式会社吉野工業所 |
吸引器具
|
|
RU2544801C2
(ru)
*
|
2013-06-11 |
2015-03-20 |
Открытое Акционерное Общество "Фармацевтическая Фабрика Санкт-Петербурга" |
Порошковый ингалятор
|
|
EP2848615A1
(en)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
New pyrazole derivatives as CRAC channel modulators
|
|
USD737425S1
(en)
|
2013-07-09 |
2015-08-25 |
Celon Pharma S.A. |
Inhaler
|
|
USD746378S1
(en)
|
2013-07-30 |
2015-12-29 |
Celon Pharma S.A. |
Label for an inhaler
|
|
USD759163S1
(en)
|
2013-07-30 |
2016-06-14 |
Celon Pharma S.A. |
Label for an inhaler
|
|
CN103624401B
(zh)
*
|
2013-08-20 |
2016-03-02 |
南京理工大学 |
立式定量控制的自动爆炸复合炸药铺放装置
|
|
WO2015091285A1
(en)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Dosage formulation comprising salmeterol and fluticasone propionate
|
|
CN106061532A
(zh)
|
2013-12-23 |
2016-10-26 |
格兰马克药品有限公司 |
干粉吸入器
|
|
SG11201609276RA
(en)
|
2014-05-12 |
2016-12-29 |
Glaxosmithkline Ip No 2 Ltd |
Pharmaceutical compositions comprising danirixin for treating infectious diseases
|
|
JP6758196B2
(ja)
|
2014-05-28 |
2020-09-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Copdの治療におけるフルチカゾンフランカルボン酸エステル
|
|
MA39288A
(fr)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret As |
Formulations pharmaceutiques comprenant du vilanterol
|
|
EP2957553A1
(en)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations of vilanterol
|
|
TR201407010A2
(tr)
|
2014-06-16 |
2015-12-21 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Vilanterol formülasyonları.
|
|
EP2957552B1
(en)
|
2014-06-16 |
2020-01-22 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Vilanterol formulations
|
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
|
US9550032B2
(en)
*
|
2014-10-12 |
2017-01-24 |
Kendra Baldwin |
Wearable wrist inhaler
|
|
CA2965759C
(en)
|
2014-10-31 |
2023-12-12 |
Glaxosmithkline Intellectual Property Development Limited |
Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
|
|
CN107427650A
(zh)
|
2015-01-14 |
2017-12-01 |
瑞必治公司 |
粉末分散方法和装置
|
|
GB201503720D0
(en)
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
|
RU2017134274A
(ru)
|
2015-03-11 |
2019-04-03 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Связывающие tslp белки
|
|
USD767114S1
(en)
|
2015-03-18 |
2016-09-20 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
|
USD769439S1
(en)
|
2015-03-18 |
2016-10-18 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
|
GB201504689D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
WO2016161830A1
(zh)
*
|
2015-04-09 |
2016-10-13 |
正大天晴药业集团股份有限公司 |
药物释放带
|
|
CN106139335B
(zh)
*
|
2015-04-09 |
2022-12-16 |
正大天晴药业集团股份有限公司 |
一种药粉释放装置
|
|
TWI597079B
(zh)
|
2015-04-10 |
2017-09-01 |
微劑量醫療公司 |
泡殼帶進給機構
|
|
WO2016170009A1
(en)
|
2015-04-21 |
2016-10-27 |
Almirall, S.A. |
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
|
|
AU364719S
(en)
|
2015-05-20 |
2015-10-14 |
Korea United Pharm Inc |
Medicine inhaler
|
|
KR20180018684A
(ko)
|
2015-06-15 |
2018-02-21 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Nrf2 조절제
|
|
HUE066668T2
(hu)
|
2015-06-15 |
2024-08-28 |
Glaxosmithkline Intellectual Property Dev |
NRF2-szabályozók
|
|
JP2018517732A
(ja)
|
2015-06-15 |
2018-07-05 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーター
|
|
WO2016202800A1
(en)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
|
CN107614037B
(zh)
*
|
2015-07-29 |
2021-09-03 |
正大天晴药业集团股份有限公司 |
药物释放带
|
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
|
RU2018112312A
(ru)
|
2015-09-22 |
2019-10-23 |
ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед |
Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена
|
|
US10351530B2
(en)
|
2015-10-06 |
2019-07-16 |
Glaxosmithkline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as NRF2 regulators
|
|
EP3359532A1
(en)
|
2015-10-06 |
2018-08-15 |
GlaxoSmithKline Intellectual Property Development Limited |
Biaryl pyrazoles as nrf2 regulators
|
|
WO2017085692A1
(en)
|
2015-11-18 |
2017-05-26 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pharmaceutical compositions of ribavirin
|
|
GB201604680D0
(en)
|
2016-03-21 |
2016-05-04 |
Glaxosmithkline Ip Dev Ltd |
Chemical Compounds
|
|
KR20180132682A
(ko)
|
2016-04-07 |
2018-12-12 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
브로모도메인 억제제로서의 피리딜 유도체
|
|
CA3018275A1
(en)
|
2016-04-07 |
2017-10-12 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Benzo[b]furans as bromodomain inhibitors
|
|
WO2017176291A1
(en)
*
|
2016-04-08 |
2017-10-12 |
Kendra Baldwin T |
Wearable wrist inhaler
|
|
RU2018142988A
(ru)
|
2016-05-24 |
2020-06-25 |
ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед |
Производные пиридиндикарбоксамида в качестве ингибиторов бромодомена
|
|
GB201614940D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
GB201614939D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
|
GB201614934D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
US10590077B2
(en)
|
2016-09-20 |
2020-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
TRPV4 antagonists
|
|
AU2017330620A1
(en)
|
2016-09-20 |
2019-03-28 |
Glaxosmithkline Intellectual Property (No.2) Limited |
TRPV4 antagonists
|
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
|
CN109045428B
(zh)
*
|
2016-10-03 |
2021-06-29 |
捷普科技(上海)有限公司 |
药剂分配器
|
|
WO2018094392A1
(en)
|
2016-11-21 |
2018-05-24 |
Lupin Inc. |
Medicament dispenser
|
|
WO2018104766A1
(en)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
3-(2,3-dihydro-1h-inden-5-yl)propanoic acid derivatives and their use as nrf2 regulators
|
|
JP2020500919A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしての3−カルボン酸ピロール
|
|
EP3551621A1
(en)
|
2016-12-12 |
2019-10-16 |
GlaxoSmithKline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
|
ES2848699T3
(es)
|
2016-12-14 |
2021-08-11 |
Glaxosmithkline Ip Dev Ltd |
Compuestos de 3-oxo-1,4-diazepinilo como activadores de NRF2
|
|
ES2901617T3
(es)
|
2016-12-14 |
2022-03-23 |
Glaxosmithkline Ip Dev Ltd |
Bisarilamidas como reguladores de NRF2
|
|
WO2018109643A1
(en)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as nrf2 acti
|
|
ES2908941T3
(es)
|
2016-12-15 |
2022-05-04 |
Glaxosmithkline Ip Dev Ltd |
Triazoles unidos a éter como reguladores de NRF2
|
|
US11028099B2
(en)
|
2016-12-15 |
2021-06-08 |
Glaxosmithkline Intellectual Property Development Limited |
NRF2 activators
|
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
|
GB201703282D0
(en)
|
2017-03-01 |
2017-04-12 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
|
CN108622469B
(zh)
*
|
2017-03-24 |
2023-08-15 |
李和伟 |
一种独立包装的履带式给药器
|
|
JP2020515587A
(ja)
|
2017-03-31 |
2020-05-28 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
免疫原性組成物、使用及び処置方法
|
|
MY199746A
(en)
|
2017-04-24 |
2023-11-21 |
Cocrystal Pharma Inc |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
|
JP7275129B2
(ja)
|
2017-07-25 |
2023-05-17 |
アドヒアリアム(エヌ・ズィー)リミテッド |
アドヒアランスを監視する方法および装置
|
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Nrf2路徑的新穎化合物
|
|
GB201716369D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
|
GB201716392D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
JP2021505636A
(ja)
|
2017-12-11 |
2021-02-18 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
急性肺傷害、急性呼吸促迫症候群および多臓器不全症候群の処置のためのnrf2アクチベーター
|
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
AU2019208416B2
(en)
|
2018-01-17 |
2021-07-29 |
Glaxosmithkline Intellectual Property Development Limited |
PI4KIIIbeta inhibitors
|
|
CN110237373B
(zh)
*
|
2018-03-08 |
2023-06-02 |
润生药业有限公司 |
一种生产用于联合用药的药物载体的装置及方法
|
|
WO2019195711A1
(en)
|
2018-04-06 |
2019-10-10 |
Lupin Inc. |
Medicament dispenser
|
|
EP3796906A1
(en)
|
2018-05-23 |
2021-03-31 |
GlaxoSmithKline Intellectual Property Management Limited |
Indanes as nrf2 activators
|
|
MX2021000917A
(es)
|
2018-07-27 |
2021-06-23 |
Cocrystal Pharma Inc |
Derivados de pirrolo[2,3-b]piridina como inhibidores de la replicación del virus de la gripe.
|
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
|
GB201814167D0
(en)
|
2018-08-31 |
2018-10-17 |
Glaxosmithkline Ip No 2 Ltd |
Compounds
|
|
CA3112309C
(en)
|
2018-09-10 |
2024-06-04 |
Cipla Limited |
Single blister-strip based dispenser
|
|
ES2937837T3
(es)
|
2018-09-10 |
2023-03-31 |
Cocrystal Pharma Inc |
Inhibidores de piridopirazina y piridotriazina de la replicación del virus de la gripe
|
|
KR102890706B1
(ko)
|
2018-10-17 |
2025-11-24 |
코크리스탈 파마, 아이엔씨. |
인플루엔자 바이러스 복제 억제제의 조합물
|
|
KR102873231B1
(ko)
|
2018-11-13 |
2025-10-17 |
코크리스탈 파마, 아이엔씨. |
인플루엔자 치료제 제형
|
|
US20220048897A1
(en)
|
2018-11-26 |
2022-02-17 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
|
CN114072136B
(zh)
|
2019-04-29 |
2024-11-29 |
英斯梅德股份有限公司 |
曲前列素前药的干粉组合物及其使用方法
|
|
EP3750528A1
(en)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Compositions for treating dystrophies and myotonia
|
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
|
WO2021175983A1
(en)
|
2020-03-06 |
2021-09-10 |
Vectura Delivery Devices Limited |
Process for manufacturing a blister strip for a dry powder inhaler
|
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
|
IL296794A
(en)
|
2020-03-25 |
2022-11-01 |
Lupin Inc |
Multi-carrier medicament dispensers
|
|
US20230159453A1
(en)
|
2020-04-10 |
2023-05-25 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
|
WO2021216547A1
(en)
|
2020-04-20 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
|
DK4061457T3
(da)
|
2020-06-15 |
2025-02-03 |
Norton Waterford Ltd |
Inhalator omfattende en blisterpakning
|
|
PL244222B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
|
PL244221B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
|
JP2024510717A
(ja)
|
2021-02-22 |
2024-03-11 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物、使用及び方法
|
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
|
TW202321196A
(zh)
|
2021-08-03 |
2023-06-01 |
美商共結晶製藥公司 |
冠狀病毒抑制劑
|
|
GB202111658D0
(en)
|
2021-08-13 |
2021-09-29 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
ES2981159T3
(es)
|
2021-08-13 |
2024-10-07 |
Norton Waterford Ltd |
Inhalador de medicamento de polvo seco
|
|
PT4221793T
(pt)
|
2021-09-29 |
2025-05-26 |
Norton Waterford Ltd |
Inalador de medicamento em pó seco
|
|
PL4221793T3
(pl)
|
2021-09-29 |
2025-06-23 |
Norton (Waterford) Limited |
Inhalator do leków w postaci suchego proszku
|
|
ES3031159T3
(en)
|
2021-09-29 |
2025-07-04 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
GB202113921D0
(en)
|
2021-09-29 |
2021-11-10 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
CN114178071B
(zh)
*
|
2021-12-10 |
2022-09-09 |
杭州博乐工业设计股份有限公司 |
一种可更换储液设备的喷雾器
|
|
WO2023150747A1
(en)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Dry powder compositions of bedaquiline and salts and methods of use thereof
|
|
GB2618145A
(en)
*
|
2022-04-29 |
2023-11-01 |
Merxin Ltd |
Manifold
|
|
US12502490B2
(en)
|
2022-04-29 |
2025-12-23 |
Merxin Ltd |
Manifold
|
|
EP4591907A3
(en)
|
2024-01-23 |
2025-09-10 |
Zeteo Biomedical LLC |
Multi-chambered powder dispense system
|